IL6 and COVID-19: Moreover, acute inflammatory cytokine (IL-6) release in COVID-19 patients is known to precipitate acute kidney injury (AKI), glomerular pathology,[37] acute tubular necrosis, leading to PCT damage,[36] and electrolyte abnormalities.